Date | Insider | Price | Amount |
---|---|---|---|
7-10-2015 Insider Buy |
Andrew L. Pecora Director |
$2.68 CAGR » |
$133,944.27 50,000 shares |
7-9-2015 Insider Buy |
Andrew L. Pecora Director |
$2.40 CAGR » |
$120,090.00 50,000 shares |
7-2-2015 Insider Buy |
Paul J. Schmitt Director |
$2.34 CAGR » |
$23,356.90 10,000 shares |
3-27-2015 Insider Buy |
Pete A. Meyers CFO & Treasurer |
$4.35 CAGR » |
$21,750.00 5,000 shares |
3-26-2015 Insider Buy |
J. Kevin Buchi President & CEO |
$4.23 CAGR » |
$21,147.50 5,000 shares |
12-10-2014 Insider Buy |
Colin Glenn Begley Chief Scientific Officer & SVP |
$6.16 CAGR » |
$36,960.00 6,000 shares |
1-7-2015 Insider Buy |
J. Kevin Buchi President & CEO |
$5.04 CAGR » |
$25,181.00 5,000 shares |
12-9-2014 Insider Buy |
J. Kevin Buchi President & CEO |
$6.01 CAGR » |
$30,060.00 5,000 shares |
12-4-2014 Insider Buy |
Pete A. Meyers CFO & Treasurer |
$4.94 CAGR » |
$5,107.96 1,034 shares |
12-2-2014 Insider Buy |
J. Kevin Buchi President & CEO |
$4.99 CAGR » |
$49,900.00 10,000 shares |
11-26-2014 Insider Buy |
Colin Glenn Begley Chief Scientific Officer & SVP |
$4.86 CAGR » |
$15,061.94 3,100 shares |
11-26-2014 Insider Buy |
Lesley Russell Chief Operating Officer |
$4.90 CAGR » |
$97,970.00 20,000 shares |
11-25-2014 Insider Buy |
Colin Glenn Begley Chief Scientific Officer & SVP |
$4.85 CAGR » |
$9,706.93 2,000 shares |
11-18-2014 Insider Buy |
J. Kevin Buchi President & CEO |
$4.82 CAGR » |
$48,185.00 10,000 shares |
11-17-2014 Insider Buy |
Andrew L. Pecora Director |
$4.53 CAGR » |
$90,640.00 20,000 shares |
11-12-2014 Insider Buy |
Peter A. Meyers CFO & Treasurer |
$3.98 CAGR » |
$19,890.00 5,000 shares |
11-11-2014 Insider Buy |
J. Kevin Buchi President and CEO |
$3.93 CAGR » |
$39,325.00 10,000 shares |
11-10-2014 Insider Buy |
Paul J. Schmitt Director |
$4.10 CAGR » |
$81,982.00 20,000 shares |
12-17-2013 Insider Buy |
James N. Woody Director |
$7.00 CAGR » |
$1,829,989.00 261,427 shares |
12-17-2013 Insider Buy |
Douglas Reed, M.D. Director |
$7.00 CAGR » |
$999,999.00 142,857 shares |
12-17-2013 Insider Buy |
Clarus Lifesciences II, L.P. >10% Owner |
$7.00 CAGR » |
$9,975,441.00 1,425,063 shares |
12-17-2013 Insider Buy |
Andrew L. Pecora Director |
$7.00 CAGR » |
$185,857.00 26,551 shares |
12-17-2013 Insider Buy |
J. Kevin Buchi President and CEO |
$7.00 CAGR » |
$1,999,998.00 285,714 shares |
12-17-2013 Insider Buy |
Paul J. Schmitt Director |
$7.00 CAGR » |
$3,116,253.00 445,179 shares |
12-17-2013 Insider Buy |
Peter A. Meyers CFO & Treasurer |
$7.00 CAGR » |
$999,999.00 142,857 shares |
12-17-2013 Insider Buy |
Inc Amgen >10% Owner |
$7.00 CAGR » |
$1,904,994.00 272,142 shares |
12-17-2013 Insider Buy |
Ventures Vii LP Healthcare >10% Owner |
$7.00 CAGR » |
$4,994,241.00 713,463 shares |
Also See: Institutional Holders of TLOG
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 07/13/2015 | |
End date: | 09/22/2022 | |
Start price/share: | $2.81 | |
End price/share: | $0.01 | |
Dividends collected/share: | $0.00 | |
Total return: | -99.82% | |
Average Annual Total Return: | -58.49% | |
Starting investment: | $10,000.00 | |
Ending investment: | $17.81 | |
Years: | 7.20 |
TLOG Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent TLOG insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding TLOG
Free TLOG Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |